title: Clinicopathological significance of loss of ARID1A immunoreactivity in ovarian clear cell carcinoma.
abstract: Recent genome-wide analysis has demonstrated that somatic mutations in ARID1A (BAF250) are the most common molecular genetic changes in ovarian clear cell carcinoma (OCCC). ARID1A mutations, which occur in approximately half of OCCC cases, lead to deletion of the encoded protein and inactivation of the putative tumor suppressor. In this study, we determined the significance of loss of ARID1A immunoreactivity with respect to several clinicopathological features in a total of 149 OCCCs. First, we demonstrated that ARID1A immunohistochemistry showed concordance with the mutational status in 91% of cases with 100% sensitivity and 66% specificity. Specifically, among 12 OCCC cases for which ARIDA mutational status was known, ARIDIA immunoreactivity was undetectable in all 9 cases harboring ARID1A mutations and was undetectable in one of 3 cases with wild-type ARID1A. With respect to the entire cohort, ARID1A immunoreactivity was undetectable in 88 (59%) of 149 OCCCs. There was no significant difference between ARID1A negative and positive cases in terms of histopathologic features, age, clinical stage, or overall survival. In conclusion, this study provides further evidence that mutations in ARID1A resulted in loss of ARID1A protein expression in OCCC, although no significant differences between ARID1A positive and negative cases were observed with respect to any clinicopathological features examined.
authors: Department of Pathology, Graduate School of Medicine, the University of Tokyo, Tokyo, Japan; E-Mails: daichimaeda@gmail.com (D.M.); mfukayama-tky@umin.net (M.F.).
authors: Daichi
authors: D
authors: Maeda
authors: Tsui-Lien
authors: TL
authors: Mao
authors: Masashi
authors: M
authors: Fukayama
authors: Shunsuke
authors: S
authors: Nakagawa
authors: Tetsu
authors: T
authors: Yano
authors: Yuji
authors: Y
authors: Taketani
authors: Ie-Ming
authors: IeM
authors: Shih
references: Clin Cancer Res. 2010 Apr 1;16(7):1997-2008
references: 20233889
references: N Engl J Med. 2010 Oct 14;363(16):1532-43
references: 20942669
references: Genes Chromosomes Cancer. 2007 Aug;46(8):745-50
references: 17492758
references: Am J Surg Pathol. 2009 Jun;33(6):844-53
references: 19342944
references: Oncogene. 2009 Apr 9;28(14):1653-68
references: 19234488
references: Science. 2010 Oct 8;330(6001):228-31
references: 20826764
references: Nature. 2010 Jan 28;463(7280):474-84
references: 20110991
references: Cancer Res. 2005 Oct 15;65(20):9236-44
references: 16230384
references: Biochem Biophys Res Commun. 2009 Aug 7;385(4):586-90
references: 19486893
references: Biochem J. 2004 Oct 15;383(Pt 2):319-25
references: 15170388
references: Proc Natl Acad Sci U S A. 2008 May 6;105(18):6656-61
references: 18448678